BIONICAL LIMITED
Get an alert when BIONICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-11 (in 6mo)
Last made up 2025-10-28
Watchouts
None on the register
Cash
£3M
+79.1% vs 2023
Net assets
-£9M
-56.3% vs 2023
Employees
228
+2.7% vs 2023
Profit before tax
-£3M
-301.5% vs 2023
Name history
Renamed 2 times since incorporation
- BIONICAL LIMITED 2014-11-07 → present
- ELLIS PHARMA LIMITED 2009-11-12 → 2014-11-07
- ELLIOTT PHARMA LIMITED 2009-10-28 → 2009-11-12
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £82,752,000 | £53,413,000 | |
| Operating profit | £922,000 | -£3,979,000 | |
| Profit before tax | -£860,000 | -£3,453,000 | |
| Net profit | -£932,000 | -£3,512,000 | |
| Cash | £1,889,000 | £3,383,000 | |
| Total assets less current liabilities | £3,472,000 | £4,106,000 | |
| Net assets | -£5,980,000 | -£9,346,000 | |
| Equity | -£5,980,000 | -£9,346,000 | |
| Average employees | 222 | 228 | |
| Wages | £15,835,000 | £13,963,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 1.1% | -7.4% | |
| Net margin | -1.1% | -6.6% | |
| Return on capital employed | 26.6% | -96.9% | |
| Gearing (liabilities / total assets) | 133.9% | 156.7% | |
| Current ratio | — | 1.11x | |
| Interest cover | 0.51x | -1.77x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis which the directors believe to be appropriate for the following reasons. The directors have prepared cash flow forecasts for a 12 month period from the date of approval of these financial statements and such forecasts have indicated that sufficient funds should be available”
Group structure
- BIONICAL LIMITED · parent
- Bionical EMAS Inc 100%
- Bionical EMAS GmbH 100%
- Bionical EMAS Limited 100%
- EMAS Pharma SA 100%
Significant events
- “In December 2024, the Group disposed of its Clinical Development division.”
- “The exceptional items relate to settlement agreements, legal fees, costs of disposing of the Clinical Development division and restructuring of Irish operations.”
- “On 7 December 2024 the group disposed of its 100% holding in EMAS Pharma Limited, EMAS Pharma Pty Limited and EMAS Pharma, Inc for a total consideration of £5,524,000.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BORKOWSKI, Andrew Thomas | Director | 2016-01-01 | Jun 1962 | British |
| LEAVER, Andrew Derrick | Director | 2009-10-28 | Dec 1962 | British |
| WATSON, Tom | Director | 2022-03-01 | Sep 1977 | British |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HOLLINGWORTH, Angela Helen | Secretary | 2011-07-31 | 2012-04-24 |
| THOMAS, Lucy Kate | Secretary | 2012-04-24 | 2015-12-08 |
| WOOD, Robert Macgregor Warburton | Secretary | 2009-10-28 | 2011-07-31 |
| BRACEY, Jonathan Edward | Director | 2013-09-01 | 2014-06-27 |
| CAMPBELL, Gary | Director | 2012-04-24 | 2013-10-31 |
| LEAVER, Darren | Director | 2019-01-10 | 2022-03-01 |
| LEAVER, Linda | Director | 2009-10-28 | 2012-12-31 |
| MCINTOSH, Graham | Director | 2014-01-06 | 2018-07-12 |
| WARING-HUGHES, Jonathan | Director | 2019-01-10 | 2022-08-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Andrew Derrick Leaver | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 96 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-06-15 RESOLUTIONS Resolution
- 2023-05-19 MA Memorandum articles
- 2023-05-19 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-21 | RP01PSC01 | miscellaneous | Legacy | |
| 2025-10-06 | AA | accounts | Accounts with accounts type group | |
| 2025-01-17 | CH01 | officers | Change person director company with change date | |
| 2025-01-17 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2024-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-09 | AA | accounts | Accounts with accounts type group | |
| 2024-05-02 | CH01 | officers | Change person director company with change date | |
| 2023-12-29 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2023-11-30 | CH01 | officers | Change person director company with change date | |
| 2023-11-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-11-11 | AA | accounts | Accounts with accounts type group | |
| 2023-06-15 | RESOLUTIONS | resolution | Resolution | |
| 2023-06-07 | SH01 | capital | Capital allotment shares | |
| 2023-05-19 | SH01 | capital | Capital allotment shares | |
| 2023-05-19 | MA | incorporation | Memorandum articles | |
| 2023-05-19 | RESOLUTIONS | resolution | Resolution | |
| 2023-01-07 | AA | accounts | Accounts with accounts type group | |
| 2022-11-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-23 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-35.5%
£82,752,000 £53,413,000
-
Cash
+79.1%
£1,889,000 £3,383,000
-
Net assets
-56.3%
-£5,980,000 -£9,346,000
-
Employees
+2.7%
222 228
-
Operating profit
-531.6%
£922,000 -£3,979,000
-
Profit before tax
-301.5%
-£860,000 -£3,453,000
-
Wages
-11.8%
£15,835,000 £13,963,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers